Hi everyone,
I don't want to be overly commercial and will keep this as brief as possible, but I just wanted to announce that Westmed, Inc. received FDA 510(k) clearance to market for its Vibralung® Acoustical Percussor on May 23, 2014. The official press releases will occur soon and the product launch will take place in late summer. The Westmed website is being modernized and updated and the new web site will also be relaunched soon along with a comprehensive family of web pages devoted to the Vibralung. I'll make an announcement when those sites are up and running.
The operating theory of the Vibralung Acoustical Percussor is to vibrate the "column" of air in the tracheobronchial tract, using sound waves, which also vibrates the different airways and the mucus at their specific Resonant Frequencies (RFs). This is called "sympathetic resonance," and a good real-world example is when a car pulls up next to yours with its stereo system pumping out at such extremely high volume that it causes your car to rattle and vibrate. This is what is accomplished in the lungs during therapy with the Vibralung.
In short, the Vibralung Acoustical Percussor is an acoustic airway clearance device that applies sound waves directly to the airway opening through a mouthpiece during both inspiration and exhalation while the subject is breathing normally. A veterinary version has been in use for many years to clear the lungs of race horses and now Westmed has developed a version of that device that is suitable for humans. The sound waves that are generated include "random noise" between 5 and 1,200 Hz plus 3 different modes of sequential tone pulses that are applied in different frequency ranges during a 10 minute timed treatment session: Low 5 - 200 Hz, Medium 5 - 600 Hz, and High 5 - 1,200 Hz. Simultaneous aerosol therapy can also be given via the Westmed Circulaire II high-efficiency aerosol drug delivery system.
The device consists of 2 components: an ergonomically shaped Hand-Held Transducer (HHT) connected with a tiny wire to a small, portable battery-operated Treatment Control Unit (TCU).
The reason for the different ranges and sequential frequency progression during the treatment is because each airway segment has its own RF, determined in part by its length and diameter. Treating the lung with a single frequency is likely to be effective on some airways but bypass many others that have different sizes and therefore different RFs. Treating the lung with a progression that includes hundreds of discrete frequencies will eventually expose virtually the entire airway system to acoustic vibration at some point during the treatment.
We will make additional announcements in the future and will also formally communicate with the CFF as the launch date becomes set. So please watch for the announcements this summer and stay tuned for further information.
Thank you for allowing me this brief announcement.
Mike
Michael McPeck, RRT FAARC
Director of Clinical Education
Westmed, Inc.
Tucson, AZ
I don't want to be overly commercial and will keep this as brief as possible, but I just wanted to announce that Westmed, Inc. received FDA 510(k) clearance to market for its Vibralung® Acoustical Percussor on May 23, 2014. The official press releases will occur soon and the product launch will take place in late summer. The Westmed website is being modernized and updated and the new web site will also be relaunched soon along with a comprehensive family of web pages devoted to the Vibralung. I'll make an announcement when those sites are up and running.
The operating theory of the Vibralung Acoustical Percussor is to vibrate the "column" of air in the tracheobronchial tract, using sound waves, which also vibrates the different airways and the mucus at their specific Resonant Frequencies (RFs). This is called "sympathetic resonance," and a good real-world example is when a car pulls up next to yours with its stereo system pumping out at such extremely high volume that it causes your car to rattle and vibrate. This is what is accomplished in the lungs during therapy with the Vibralung.
In short, the Vibralung Acoustical Percussor is an acoustic airway clearance device that applies sound waves directly to the airway opening through a mouthpiece during both inspiration and exhalation while the subject is breathing normally. A veterinary version has been in use for many years to clear the lungs of race horses and now Westmed has developed a version of that device that is suitable for humans. The sound waves that are generated include "random noise" between 5 and 1,200 Hz plus 3 different modes of sequential tone pulses that are applied in different frequency ranges during a 10 minute timed treatment session: Low 5 - 200 Hz, Medium 5 - 600 Hz, and High 5 - 1,200 Hz. Simultaneous aerosol therapy can also be given via the Westmed Circulaire II high-efficiency aerosol drug delivery system.
The device consists of 2 components: an ergonomically shaped Hand-Held Transducer (HHT) connected with a tiny wire to a small, portable battery-operated Treatment Control Unit (TCU).
The reason for the different ranges and sequential frequency progression during the treatment is because each airway segment has its own RF, determined in part by its length and diameter. Treating the lung with a single frequency is likely to be effective on some airways but bypass many others that have different sizes and therefore different RFs. Treating the lung with a progression that includes hundreds of discrete frequencies will eventually expose virtually the entire airway system to acoustic vibration at some point during the treatment.
We will make additional announcements in the future and will also formally communicate with the CFF as the launch date becomes set. So please watch for the announcements this summer and stay tuned for further information.
Thank you for allowing me this brief announcement.
Mike
Michael McPeck, RRT FAARC
Director of Clinical Education
Westmed, Inc.
Tucson, AZ